Rauha Tulkki-Wilke | Director of Product Management
CRF Health

Rauha Tulkki-Wilke, Director of Product Management, CRF Health

Rauha Tulkki-Wilke works at CRF Health, a company providing ePRO solutions to clinical trials, where she manages the development of new ePRO solutions for the pharmaceutical industry. Rauha has been with CRF Health since it was founded and has more than 10 years of experience with ePRO: developing new, patient-friendly ePRO solutions and delivering them to clinical trials. She has also been one of the pioneers in SMS-based patient compliance management solutions. Since 2001 she has developed and delivered connection programs and facilitating technologies as part of the CRF Health team. Rauha holds an MSc in Biophysics and Biomedical Engineering. During her studies she focused on functional brain imaging technologies. She has a genuine interest in eHealth. Prior to moving to the pharmaceutical sector, she developed solutions for anesthesia management and neonatal intensive care at Datex-Ohmeda, a GE Healthcare company.

Share this

Appearances at this years' conference:

Day Two Thursday 22 March 2012


@ 10.10
High patient compliance and retention through engaging online data capture

• Higher scientific value of patient reported outcomes via online tools
• Ways to improve patient compliance and retention in long studies

  • › Rauha Tulkki-Wilke, Director of Product Management, CRF Health
Sponsors
Session Facilitators
PRA International at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Medidata Solutions Inc at Late Phase Drug Development World Americas 2012
Session presentation sponsor
OptumInsight at Late Phase Drug Development World Americas 2012
Session presentation sponsor
Oracle Corporation UK Limited at Late Phase Drug Development World Americas 2012
Session presentation sponsor
CRF Health at Late Phase Drug Development World Americas 2012
Session presentation sponsor
PharmaNet/i3 at Late Phase Drug Development World Americas 2012
Session presentation sponsor
United BioSource Corporation at Late Phase Drug Development World Americas 2012